Stay updated on KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial

Sign up to get notified when there's something new on the KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    4%
    Check dated 2025-06-20T18:17:37.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.3%
    Check dated 2025-06-13T15:58:21.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.3%
    Check dated 2025-06-06T09:35:36.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, and API users can provide input before this change. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    6%
    Check dated 2025-05-30T04:35:27.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    1.0%
    Check dated 2025-05-23T01:34:20.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The study of KPT-8602 in participants with relapsed/refractory cancer indications has been completely removed from the page.
    Difference
    0.3%
    Check dated 2025-05-15T20:00:14.000Z thumbnail image

Stay in the know with updates to KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial page.